KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Debt Ratio (2023 - 2025)

Biocryst Pharmaceuticals' Debt Ratio history spans 8 years, with the latest figure at 0.07 for Q4 2025.

  • For Q4 2025, Debt Ratio fell 89.45% year-over-year to 0.07; the TTM value through Dec 2025 reached 0.07, down 89.45%, while the annual FY2025 figure was 0.07, 89.45% down from the prior year.
  • Debt Ratio reached 0.07 in Q4 2025 per BCRX's latest filing, down from 0.52 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.73 in Q1 2025 to a low of 0.07 in Q4 2025.
  • Average Debt Ratio over 3 years is 0.58, with a median of 0.62 recorded in 2023.
  • Peak YoY movement for Debt Ratio: soared 56.73% in 2024, then tumbled 89.45% in 2025.
  • A 3-year view of Debt Ratio shows it stood at 0.63 in 2023, then increased by 12.1% to 0.71 in 2024, then crashed by 89.45% to 0.07 in 2025.
  • Per Business Quant, the three most recent readings for BCRX's Debt Ratio are 0.07 (Q4 2025), 0.52 (Q3 2025), and 0.61 (Q2 2025).